Details of the Drug

General Information of Drug (ID: DMK0NGB)

Drug Name
Rozanolixizumab
Indication
Disease Entry ICD 11 Status REF
Generalized myasthenia gravis 8C60 Approved [1]
Myasthenia gravis 8C6Y Phase 2 [2]
Cross-matching ID
DrugBank ID
DB14919
TTD ID
D01TWG
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Immunoglobulin Fc receptor (FCR) TTPY4SE NOUNIPROTAC Antagonist [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 FDA Approved Drug Products from FDA Official Website. 2023. Application Number: 761286
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)